SCM
TGTX icon

Sio Capital Management’s TG Therapeutics TGTX Stock Holding History

Sio Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-76,924
Closed -$1.19M – 45
2015
Q1 		$1.19M Sell
76,924
-25,776
-25% -$390K 0.68% 26
2014
Q4 		$1.63M Buy
+102,700
New +$1.34M 1.28% 23

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Sio Capital Management's TGTX Position: Q2 2015 in Review

Sio Capital Management sold out of TG Therapeutics (TGTX) in Q2 2015, closing a stake of 76,924 shares — an estimated $1.19M sold.

Sio Capital Management first reported a position in TGTX in Q4 2014 and held it in 2 quarters. The position peaked at $1.63M in Q4 2014. 90 funds tracked by Wall St. Rank hold TGTX as of Q2 2015.

  • Sio Capital Management reported no remaining TG Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Sio Capital Management sold 76,924 TG Therapeutics shares in Q2 2015, an estimated $1.19M.
  • Sio Capital Management first reported a position in TG Therapeutics in Q4 2014 and held it in 2 quarters.
  • Sio Capital Management's TG Therapeutics position peaked at $1.63M in Q4 2014.
  • 90 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2015.

Based on Sio Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.